ES2059854T3 - Nuevo polipeptido y su produccion. - Google Patents

Nuevo polipeptido y su produccion.

Info

Publication number
ES2059854T3
ES2059854T3 ES90104419T ES90104419T ES2059854T3 ES 2059854 T3 ES2059854 T3 ES 2059854T3 ES 90104419 T ES90104419 T ES 90104419T ES 90104419 T ES90104419 T ES 90104419T ES 2059854 T3 ES2059854 T3 ES 2059854T3
Authority
ES
Spain
Prior art keywords
polypeptide
useful
vector
production
transformant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90104419T
Other languages
English (en)
Inventor
Kazuo Nakahama
Yoshihiko Kaisho
Koji Yoshimura
Reiko Sasada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27463714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2059854(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2059854T3 publication Critical patent/ES2059854T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SON DESCUBIERTOS (1) UN POLIPEPTIDO (I) QUE INCLUYE LA SIGUIENTE SECUENCIA (II) DE ACIDO AMINO EN UNA MOLECULA DE ELLO: (FORMULA II) (2) UN CODIGO DE SECUENCIA DNA PARA EL POLIPEPTIDO DESCRITO EN (1),(3) UN VECTOR QUE INCLUYE EL DNA DESCRITO EN (2), (4) UN TRANSFORMANTE TRANSFORMADO POR EL VECTOR DESCRITO EN (3), Y (5) UN PROCESO PARA PRODUCIR EL POLIPEPTIDO (I) QUE COMPRENDE CULTIVAR EL TRANSFORMANTE DESCRITO EN (4) EN UN MEDIO DE CULTIVO PARA PRODUCIR Y ACUMULAR EL POLIPEPTIDO DESCRITO EN (1) EN UN CULTIVO. EL POLIPEPTIDO ES UTIL COMO UN REACTIVO PARA ESTUDIOS RELACIONADOS A LA DIFERENCIACION, CRECIMIENTO Y SUPERVIVENCIA DE CELULAS ANIMALES, Y DEBE TAMBIEN SER UTIL COMO UNA DROGA.
ES90104419T 1989-03-10 1990-03-08 Nuevo polipeptido y su produccion. Expired - Lifetime ES2059854T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5898389 1989-03-10
JP12771089 1989-05-19
JP19365489 1989-07-26
JP26361389 1989-10-09

Publications (1)

Publication Number Publication Date
ES2059854T3 true ES2059854T3 (es) 1994-11-16

Family

ID=27463714

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90104419T Expired - Lifetime ES2059854T3 (es) 1989-03-10 1990-03-08 Nuevo polipeptido y su produccion.

Country Status (11)

Country Link
US (1) US6709837B1 (es)
EP (1) EP0386752B1 (es)
JP (1) JPH0780904B2 (es)
KR (1) KR0132425B1 (es)
AT (1) ATE111521T1 (es)
CA (1) CA2011833C (es)
DE (1) DE69012377T2 (es)
DK (1) DK0386752T3 (es)
ES (1) ES2059854T3 (es)
HK (1) HK34896A (es)
IE (1) IE65361B1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656435A (en) * 1989-08-28 1997-08-12 Takeda Chemical Industries, Ltd. Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
US6933276B1 (en) 1989-08-30 2005-08-23 Regeneron Pharmaceuticals, Inc. Methods of treating peripheral neuropathies using neurotrophin-3
GR1000980B (el) * 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
DK0499993T3 (da) * 1991-02-18 1997-12-01 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af human nervevækstfaktor-2
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
EP0573904B1 (en) * 1992-06-08 2001-09-26 Takeda Chemical Industries, Ltd. Therapeutic agent for neutropenia
AU5684594A (en) * 1992-12-02 1994-06-22 Novo Nordisk A/S Novel human amyloid protein precursor homologue and kunitz-type inhibitors
JP2732005B2 (ja) * 1992-12-14 1998-03-25 眞一 富永 ヒトｓｔ２をコードするｄｎａ、該ｄｎａの発現産物、該ｄｎａを発現させることによる発現産物の製造方法
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−３遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
US5877016A (en) * 1994-03-18 1999-03-02 Genentech, Inc. Human trk receptors and neurotrophic factor inhibitors
US5681931A (en) * 1995-03-15 1997-10-28 Becton, Dickinson And Company Human restrictin
US5864018A (en) * 1996-04-16 1999-01-26 Schering Aktiengesellschaft Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
AU7301698A (en) * 1996-11-22 1998-06-10 Human Genome Sciences, Inc. Thermostable polymerases having altered fidelity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor

Also Published As

Publication number Publication date
US6709837B1 (en) 2004-03-23
DK0386752T3 (da) 1994-12-05
JPH0780904B2 (ja) 1995-08-30
DE69012377T2 (de) 1995-05-04
ATE111521T1 (de) 1994-09-15
EP0386752B1 (en) 1994-09-14
DE69012377D1 (de) 1994-10-20
KR0132425B1 (ko) 1998-04-14
JPH03204897A (ja) 1991-09-06
HK34896A (en) 1996-03-08
CA2011833C (en) 2002-11-05
CA2011833A1 (en) 1990-09-10
IE900785L (en) 1990-09-10
EP0386752A1 (en) 1990-09-12
IE65361B1 (en) 1995-10-18
KR900014428A (ko) 1990-10-23

Similar Documents

Publication Publication Date Title
ES2059854T3 (es) Nuevo polipeptido y su produccion.
DE69431142T2 (de) Zusammensetzungen und Methoden zur Strukturellen Proteinbestimmung
DE69229572D1 (de) Gliazellen-aktivierender Faktor und dessen Herstellung
DE3650788D1 (de) Produktion des pluripotenten Granulozyten-Koloniestimulierungsfaktors
ATE123295T1 (de) Rezeptor-proteine für humanen b-zellen stimulierenden faktor 2.
PT955313E (pt) Nova proteina e processo para a sua producao
ATE123065T1 (de) Proteine und deren herstellung.
DK1942189T3 (da) Fremgangsmåde til fremstilling af sekreterede proteiner
DE68914582D1 (de) Endothelin-DNA und ihre Verwendung.
DE3584460D1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
NZ211827A (en) Production of polypeptides having interferon activity, polypeptide compositions and dna
MX26714A (es) Procedimiento para la preparacion de albumina de SUERO HUMANO VECTOR Y PLASMIDO USADOS ASI COMO LEVADURA METILOTROFICA TRANSFORMADA OBTENIDA
ATE501254T1 (de) P- selectin ligandenprotein
GB2196636B (en) Production of proteins by cell culture
ATE89317T1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
DE69027466D1 (de) Achromobacter-Protease-I-Gen sowie Genprodukt
ATE221082T1 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä- b zellen und sein gen
DE69017793D1 (de) Produktion von menschlichen Nervenwachstumsfaktoren.
JPS6420086A (en) Polypeptide and production thereof
DE3851685D1 (de) Verfahren zur Herstellung von Proteinen.
DE69115270D1 (de) Protein mit fibroblasten-wachstumsfaktor-rezeptoraktivität.
CA2324649A1 (en) Human p51 genes and gene products thereof
DE69923595D1 (de) Herstellung von proteinen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 386752

Country of ref document: ES